ISOLEXT financials
A multi-period view of the public annual-account figures reported for ISOLEXT, with comparable measures and links to available source documents.
Company overviewRegistry number
0848825917
Fiscal coverage
2024–2025
Public sources
cbso_bulk
Data updated
Jul 29, 2026
Financial evidence
Latest movements for ISOLEXT
2025 versus 2024
- Operating line
- €76,889
- EBITDA
- €35,806
- Total assets
- €224,832
- Equity
- €46,019
+46%
-21.7%
-49.6%
+58.9%
EBITDA margin +46.6% · Equity ratio +20.5%
Figures reproduce public filings and may use country-specific accounting definitions. They are not audited by Upswitch.